[1] |
Han F,Li CF,Cai Z,et al.The critical role of AMPK in driving Akt activation under stress,tumorigenesis and drug resistance[J].Nat Commun,2018,9(1):4728.
|
[2] |
Liu J,Harada B T,He C.Regulation of Gene Expression by N(6)-methyladenosine in Cancer[J].Trends Cell Biol,2019,29(6):487-499.
|
[3] |
Fischer H,Ullah M,de la Cruz CC,et al.Entrectinib,a TRK/ROS1 inhibitor with anti-CNS tumor activity:differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein[J].Neuro Oncol,2020,22(6):819-829.
|
[4] |
Kabraji S,Ni J,Lin NU,et al.Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?[J].Clin Cancer Res,2018,24(8):1795-1804.
|
[5] |
Ahmad S,Ricco A,Brown R,et al.Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event and Salvage of Second Brain Metastatic Event in a Community Setting with Review of the Literature[J].Front Oncol,2017,7:32.
|
[8] |
张爽,柳菁菁,杨长良,等.驱动基因阴性非小细胞肺癌脑转移免疫治疗的研究进展[J].中国肺癌杂志,2018,21(8):610-614.
|
[9] |
Kotecha R,Gondi V,Ahluwalia MS,et al.Recent advances in managing brain metastasis[J].F1000Res,2018,7:F1000 Faculty Rev-1772.
|
[13] |
罗斌,刘阿力,孙时斌,等.脑转移瘤的伽玛刀治疗[J].中华神经外科杂志,2008,24(5):348-351.
|
[6] |
Holt DE,Gill BS,Clump DA,et al.Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis[J].Front Oncol,2015,5:84.
|
[7] |
Cheng G,Zhang Q,Pan J,et al.Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis[J].Nat Commun,2019,10(1):2205.
|
[10] |
Liu J.Initial Approach to Patients with a Newly Diagnosed Solitary Brain Metastasis[J].Neurosurg Clin N Am,2020,31(4):489-503.
|
[11] |
Uzunalli G,Dieterly AM,Kemet CM,et al.Dynamic transition of the blood-brain barrier in the development of nonsmall cell lung cancer brain metastases[J].Oncotarget,2019,10(59):6334-6348.
|
[12] |
Bowden G,Kano H,Caparosa E,et al.Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer[J].J Neurosurg,2015,122(4):766-772.
|
[14] |
Noordijk EM,Vecht CJ,Haaxma-Reiche H,et al.The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age[J].Int J Radiat Oncol Biol Phys,1994,29(4):711-717.
|
[15] |
Sanghavi SN,Miranpuri SS,Chappell R,et al.Radiosurgery for patients with brain metastases:a multi-institutional analysis,stratified by the RTOG recursive partitioning analysis method[J].Int J Radiat Oncol Biol Phys,2001,51(2):426-434.
|
[16] |
Yamamoto M,Serizawa T,Higuchi Y,et al.A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases(JLGK0901 Study Update):Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores[J].Int J Radiat Oncol Biol Phys,2017,99(1):31-40.
|
[17] |
Li J,Brown PD.The Diminishing Role of Whole-Brain Radiation Therapy in the Treatment of Brain Metastases[J].JAMA Oncol,2017,3(8):1023-1024.
|
[18] |
Andrews DW,Scott CB,Sperduto PW,et al.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases:phaseⅢresults of the RTOG 9508 randomised trial[J].Lancet,2004,363(9422):1665-1672.
|
[19] |
Hoffmann C,Distel L,Knippen S,et al.Brain volume reduction after whole-brain radiotherapy:quantification and prognostic relevance[J].Neuro Oncol,2018,20(2):268-278.
|
[20] |
Asher AL,Alvi MA,Bydon M,et al.Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis:analysis from a cooperative,prospective national registry[J].J Neurooncol,2021,152(2):299-311.
|